Loxapine
Active substance: loxapine
CAPSULE · LOXAPINE SUCCINATE 5 mg/1
United StatesActive
Marketing holder: Lannett Company, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LOXAPINE SUCCINATE · 5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-30a7-70cb-a6bf-7a8642e623a2,01a1208c-95e5-73f8-a77d-27ee49ca4c95,01a1208d-348b-7b52-a772-83751141dcac,01a1208e-acbc-71fe-be31-0cd6b3e93b3a,01a1208f-05f0-7a40-940c-9963f61db4fb;count=25 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0527-1394
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0527-1394 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0527-1394 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0527-1394 · Verified 2026-10-09 · open in source